Study of Long-Term Outcomes of Patients With Acute Lymphoblastic Leukemia Who Were Enrolled as Children on Clinical Trials EORTC-58741, EORTC-58831, EORTC-58832, or EORTC-58881 Between 1971 and 1998
NCT01298388 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3138
Last updated 2011-09-16
Summary
RATIONALE: Studying medical records and collecting questionnaires from patients who were enrolled as children in clinical trials for acute lymphoblastic leukemia may help doctors learn about long-term effects of treatment and plan the best treatment.
PURPOSE: This clinical trial is studying the long-term outcomes of patients with acute lymphoblastic leukemia who were enrolled as children on clinical trials EORTC-58741, EORTC-58831, EORTC-58832, or EORTC-58881 between 1971 and 1998.
Conditions
- Cancer Survivor
- Leukemia
- Long-term Effects Secondary to Cancer Therapy in Children
Interventions
- OTHER
-
medical chart review
- OTHER
-
questionnaire administration
- OTHER
-
study of socioeconomic and demographic variables
Sponsors & Collaborators
-
European Organisation for Research and Treatment of Cancer - EORTC
lead NETWORK
Principal Investigators
-
Caroline Piette · Centre Hospitalier Regional de la Citadelle
-
Yves Benoit, MD · University Ghent
Eligibility
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-07-31
- Primary Completion
- 2013-03-31
More Related Trials
-
Health Care Utilisation Among Survivors of Childhood Acute Lymphoblastic Leukaemia
NCT03985826 ·Status: COMPLETED
-
Evaluation of Long-term Health Status and Quality of Life in Adult Survivors With Philadelphia-negative Acute Lymphoblastic Leukemia/Lymphoma Treated With an Intensive Pediatric or Pediatric-inspired Protocol
NCT04677231 ·Status: UNKNOWN
-
Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
NCT00003437 ·Status: UNKNOWN ·Phase: PHASE3
-
Medical Research Council (MRC) Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003
NCT00222612 ·Status: UNKNOWN ·Phase: PHASE4
-
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00103285 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia
NCT00005945 ·Status: COMPLETED ·Phase: PHASE3
-
RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL
NCT05127148 ·Status: RECRUITING
-
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00005596 ·Status: COMPLETED ·Phase: PHASE3
-
ObServatory Children Acute RElated Therapy Leukemia
NCT04450784 ·Status: UNKNOWN
-
Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment
NCT02881086 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
NCT00005603 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma
NCT00195871 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study in Adults With Untreated Acute Lymphoblastic Leukemia
NCT00136435 ·Status: COMPLETED ·Phase: PHASE2
-
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
NCT07109219 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia
NCT00002499 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
NCT01190930 ·Status: COMPLETED ·Phase: PHASE3
-
Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology Branch
NCT03627208 ·Status: COMPLETED
-
Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)
NCT00131053 ·Status: UNKNOWN ·Phase: PHASE2
-
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
NCT03150693 ·Status: RECRUITING ·Phase: PHASE3
-
AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia
NCT01431664 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
NCT02883049 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
NCT03959085 ·Status: RECRUITING ·Phase: PHASE3
-
Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults
NCT00327678 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
NCT00408005 ·Status: COMPLETED ·Phase: PHASE3
-
Implementation of Innovative Techniques in Routine Diagnosis of Childhood Acute Leukemia: Analysis of Genome and Transcriptome by Micro-array
NCT02038361 ·Status: COMPLETED ·Phase: NA